Nucl Med Mol Imaging.  2018 Feb;52(1):69-73. 10.1007/s13139-016-0467-0.

Primary Renal Leiomyosarcoma Presenting with Subcutaneous and Osseous Metastases: Staging and Follow-Up with 18F-FDG PET/CT

Affiliations
  • 1Diagnostic Imaging, Cross Cancer Institute, 11560 University Ave NW, Edmonton, Alberta T6G 1Z2, Canada. makisw79@yahoo.com
  • 2MUHC Glen Site, Pathology, 1001 Decarie Blvd, Montreal, Quebec H4A 3J1, Canada.
  • 3Jewish General Hospital, Nuclear Medicine, 3755 Chemin de la Cote-Sainte-Catherine, Montreal, Quebec H3T 1E2, Canada.

Abstract

A 60 year old woman who presented with multiple small subcutaneous nodules in the upper back and arms, was referred for an [¹â¸F] fluoro-2-deoxy-D-glucose (¹â¸F-FDG) positron emission tomography/computed tomography (PET/CT) after histological evaluation revealed metastatic leiomyosarcoma of unknown origin. The PET/CT showed multiple ¹â¸F-FDG-avid subcutaneous nodules, bone lesions, as well as a large left renal mass, which was biopsied to confirm a primary renal leiomyosarcoma arising fromthe renal parenchyma.A post therapy PET/CT showed overall progression of disease. The use of 18F-FDG PET/CT in the staging and evaluation of response to therapy of a renal leiomyosarcoma has not been previously described in the literature.

Keyword

18F-FDG; Fluorodeoxyglucose; Metastases; PET/CT; Renal leiomyosarcoma

MeSH Terms

Arm
Electrons
Female
Fluorodeoxyglucose F18*
Follow-Up Studies*
Humans
Leiomyosarcoma*
Neoplasm Metastasis*
Positron-Emission Tomography and Computed Tomography*
Fluorodeoxyglucose F18
Full Text Links
  • NMMI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr